1 in knowledge translation: the critical care experience
TRANSCRIPT
1
InInKnowledge Translation: Knowledge Translation:
The Critical Care The Critical Care ExperienceExperience
Outline of SessionGuidelines for Nutrition Therapy in the ICU : How do they differ? Rupinder Dhaliwal, RD
WHAT SHOULD BE DONE?
Improving the practices of Nutrition Therapy in the Critically ill Naomi Cahill, RD
WHAT IS BEING DONE?
Bridging the Gap: Effective Dissemination Strategies for Improving Nutrition Practices in the ICUDaren Heyland, MD
HOW TO NARROW THE GAP?
Questions to be held at the end of the session
1
Guidelines for Nutrition Therapy in the Guidelines for Nutrition Therapy in the ICU: How do they differ?ICU: How do they differ?
Rupinder Dhaliwal, RD
Team Leader/Project Leader
Clinical Evaluation Research Unit
Critical Care Nutrition
Kingston ON, Canada
1
Conflict of interest
Co-author of Canadian Clinical Practice
Guidelines
Clinical practice guidelines are
“systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.”
Best available evidence with integration of potential benefits, harm, feasibility, cost
Reduce variability in care, improve quality, reduce costs and can improve outcomes
Why bother with guidelines?Why bother with guidelines?
1
Proliferation of guidelinesProliferation of guidelines
1
The more guidelines they publish, the more confused I get!
Compare the content of recently published nutrition guidelines
Differences between the recommendations
Similarities in the recommendations
Highlight the need for harmonization
ObjectivesObjectives
1
North American guidelinesNorth American guidelines
1
www.criticalcarenutrition.com
Available Online
Population Levels of Evidence Grading used Time frames, outcomes Level of transparency between evidence and
recommendation
What differences? What differences?
1
Differences Differences
Area Canadian ADA ASPEN/SCCM
Population Mechanically ventilated critically ill patients
no elective surgery
Critically ill patients needing EN
no burns
Medical and surgical critically ill patients
expected to stay in the ICU > 2-3 days
Level of evidence
RCTs, meta analyses
Level 1 or 2 based on validity of evidence
All levels of evidence
Grade 1-5 based on validity of evidence Minimum n>20
All levels of evidence
Level 1-5 based on validity of evidence
Time Frame 1980-2009 1993-20031993-20091996-2006
unclear
Outcomes clinical outcomes clinical and non clinical outcomes
clinical and non clinical outcomes
Grading Canadian ADA ASPEN/SCCM
Strongest
Weakest
“Strongly recommend”no reservations re: endorsement
(5%)
“Strong”benefits exceed harmhigh quality evidenceanticipated benefits (41%)
“A” supported by at least 2 Level 1 (RCT n > 100)(3%)
“Recommend”supportive evidence but minor uncertainties re: safety/feasibility or costs
“Fair”Same as above but quality of evidence is not as strong
“B” supported by 1 level 1
“Should be considered”Evidence was weak or major uncertainties re: safety/cost/feasibility
“Weak”Suspect quality of evidencelittle clear benefit
“C”Level 2 (RCTs <100)
“Insufficient data”Inadequate data or conflicting evidence(51%)
“Consensus”Expert opinion
“D”At least 2 Level 3(non RCT, contemporaneous controls)
“Insufficient evidence”No pertinent evidenceand harm/risk is ?(37%)
“E”Level 4 (non RCT, historical controls)Level 5 (case series), expert opinion (39%)
Criteria High Quality CPGs
1
Rigor of development: Provide detailed information on the search strategy, the
inclusion/exclusion criteria, and methods used to formulate the recommendation (reproducible).
Transparent link between evidence, values, and resulting recommendation
External review
Procedure for updating the CPG
AGREE Qual Saf Health Care 2003;12:18
Integration of values
Validity Homogeneity
SafetyFeasibility
Cost
evidence integration of values+
practiceguidelines
Indirect calorimetry vs. predictive equations
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Insufficient data
1 small RCT burn patients
Strong
Use indirect calorimetry
Non RCTs, no clinical outcomes
Grade E
Use either, caution with equations
Narrative review article
Dose of enteral nutrition and target range
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Should be considered
Use strategies to optimize EN i.e. goal rate start, 250 mls GRVs, m. agents, small bowel feeding
No threshold
1 RCT and 2 Cluster RCTs
Fair
Give at least 60-70% energy within first week
2 RCTs and 2 non RCTs
Grade C
Provide >50-65% goal calories in first week
Specifics for Obese (Grade E and D)
1 RCT and 1 non RCT
Gastric Residual Volumes & Motility agents
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
GRVs Should be considered 250 mls
1 RCT and 2 Cluster RCTs
Consensus
250 mls
Grade B
500 mls
4 RCTs
Motility agents Recommendmetoclopromide
Strongmetoclopromide
Grade CMetoclopromideErythromycinOpiod antagonists
Arginine
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Recommend NOT be used
Meta-analyses of 22 RCTs3 RCTs harm
FairNot be used
11 RCTs2 RCTS harm
Grade A SurgicalGrade B MedicalCautious in severe sepsisVolume use 50-65% goal
earlier meta-analyses showing no benefitRCT showing benefit
Grade A: based on elective surgery patients
Enteral Glutamine
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Burns: Recommended
Trauma: Should be considered
Other ICU: Insufficient data
9 RCTS
-------- Grade B
Burns, Trauma and mixed ICU patients
1 RCT
Peptides
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Recommendpolymeric (since no benefit for peptides)
4 RCTs
---------Grade E Use small peptides in diarrhea
1 non RCT
zzzz…….
Fibre
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Insufficient data
6 RCTs
---------Grade E Use soluble fibre3 RCTs
Grade CAvoid soluble and insoluble fibre for bowel ischemia/severe dysmotility2 non RCTs
Probiotics
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
Insufficient data
No benefit in outcomes, potential for harm
12 RCTs
---------Grade CUse in transplant, major abd surgery, severe trauma
Not in necrotizing pancreatitis
5 RCTs
Intensive Insulin Therapy
Differences: recommendationsDifferences: recommendations
1
Canadian ADA ASPEN/SCCM
RecommendTarget 8.0 mmol/LRange 7-9 mmol/L
Most recent meta- analyses
Strong Medical: 4.4-6.1 mmol/L
Grade BModerate strict control
Grade E6.1-8.3 mmol/L
Similarities?
Topic Canadian ADA ASPEN/SCCM
Use of EN over PN
Start EN within 24-48 hr
EN Fish Oils -----
CHO/Fat Insufficient ----- Insufficient
Body position (45) (45)
Small bowel vs. gastric
Continuous vs. other insufficient ---- High risk (D)
PN vs std care Not be used ---- Not for 7 days
Type of IV lipids No soy based ---- No soy based
PN Glutamine ----
Low dose of PN ----
AOX/vits/minerals ----
ADOPT NOW!
Slight difference in strengthSlight difference in strength
1
Enteral Nutrition over Parenteral NutritionCanadians and ADA: StrongestASPEN/SCCM: second strongest
Feeding ProtocolsCanadians and ASPEN/SCCM: weaker recommendationADA: none for feeding protocol per se, but for GRV : expert opinion
EN plus PNCanadian: recommend NOT be usedASPEN/SCCM: not be started for 7 -10 days (grade C)
Blue DyeASPEN/SCCM : not recommendADA : do not recommend but highest level of evidence
Differences exist between the guidelines: Populations, levels of evidence, time frames, etc Recommendations: due to interpretation of the evidence, lack of
transparency
Similarities in many of the recommendations
Highlight the need for harmonization across North American Societies
SummarySummary
1
Similarities should be adopted without hesitation
Differences
Harmonize between societiesDefine critically ill patientTransparency needed (websites)
Practitioner: right recommendation for the right person
ImplicationsImplications
1
Upcoming in JPEN Upcoming in JPEN
1
Available onlineKnowledge
Translation issue Fall 2010
Ahhh…..Harmonized Guidelines!